MedPath

Study on Acupoint Catgut Embedding Intervention on the Intestinal Flora of Female Patients with Abdominal Obesity

Not Applicable
Conditions
abdominal obesity
Registration Number
ITMCTR2100005072
Lead Sponsor
Yunnan University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria for abdominal obesity;
2. Females, aged from 18 to 40 years;
3. Have a certain writing and reading ability to understand the entire process of research;
4. Signed informed consent forms;
5. No other trials were taken within three months.

Exclusion Criteria

1. Extramly obese patients (BMI>=40kg/m2);
2. Secondary obesity, such as obesity caused by endocrine disease (Cushing syndrome, thyroid disease, hypothalamic disease, pituitary disease, gonadal disease, etc.) and medication (glucocorticoid or antipsychotics);
3. Pregnancy, lactation, or who have fertility requirements or are unable to provide adequate contraception within the last 6 months;
4. Mental disorder, cardiovascular disease, liver and kidney impairment, immunodeficiency, diabetes, blood disease;
5. There has been a history of surgery for obesity;
6. Patients with symptoms of gastrointestinal system, such as active peptic ulcers/bleeding, or previous recurrent ulcers/bleeding;
7. Previously undergone major intestinal excision or gastrointestinal major surgery;
8. People who take antibiotics for 3 days or more in the last 3 months;
9. Patients with long-term dysmenorrhea;
10. People who tend to bleed, or who are allergic to alcohol or animal proteins.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body Mass Index;Intestinal flora;
Secondary Outcome Measures
NameTimeMethod
waistline;Visual analogue appetite scale;weight;Gastrointestinal Symptoms Rating Scale;
© Copyright 2025. All Rights Reserved by MedPath